Live Cell Therapy as Potential Risk Factor for Q Fever

During an outbreak of Q fever in Germany, we identified an infected sheep flock from which animals were routinely used as a source for life cell therapy (LCT), the injection of fetal cells or cell extracts from sheep into humans. Q fever developed in 7 LCT recipients from Canada, Germany, and the Un...

Descripción completa

Detalles Bibliográficos
Autores principales: George, Maja, Reich, Andreas, Cussler, Klaus, Jehl, Herrmann, Burckhardt, Florian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2017
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5512499/
https://www.ncbi.nlm.nih.gov/pubmed/28296631
http://dx.doi.org/10.3201/eid2307.161693
_version_ 1783250490679623680
author George, Maja
Reich, Andreas
Cussler, Klaus
Jehl, Herrmann
Burckhardt, Florian
author_facet George, Maja
Reich, Andreas
Cussler, Klaus
Jehl, Herrmann
Burckhardt, Florian
author_sort George, Maja
collection PubMed
description During an outbreak of Q fever in Germany, we identified an infected sheep flock from which animals were routinely used as a source for life cell therapy (LCT), the injection of fetal cells or cell extracts from sheep into humans. Q fever developed in 7 LCT recipients from Canada, Germany, and the United States.
format Online
Article
Text
id pubmed-5512499
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-55124992017-07-19 Live Cell Therapy as Potential Risk Factor for Q Fever George, Maja Reich, Andreas Cussler, Klaus Jehl, Herrmann Burckhardt, Florian Emerg Infect Dis Research Letter During an outbreak of Q fever in Germany, we identified an infected sheep flock from which animals were routinely used as a source for life cell therapy (LCT), the injection of fetal cells or cell extracts from sheep into humans. Q fever developed in 7 LCT recipients from Canada, Germany, and the United States. Centers for Disease Control and Prevention 2017-07 /pmc/articles/PMC5512499/ /pubmed/28296631 http://dx.doi.org/10.3201/eid2307.161693 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Research Letter
George, Maja
Reich, Andreas
Cussler, Klaus
Jehl, Herrmann
Burckhardt, Florian
Live Cell Therapy as Potential Risk Factor for Q Fever
title Live Cell Therapy as Potential Risk Factor for Q Fever
title_full Live Cell Therapy as Potential Risk Factor for Q Fever
title_fullStr Live Cell Therapy as Potential Risk Factor for Q Fever
title_full_unstemmed Live Cell Therapy as Potential Risk Factor for Q Fever
title_short Live Cell Therapy as Potential Risk Factor for Q Fever
title_sort live cell therapy as potential risk factor for q fever
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5512499/
https://www.ncbi.nlm.nih.gov/pubmed/28296631
http://dx.doi.org/10.3201/eid2307.161693
work_keys_str_mv AT georgemaja livecelltherapyaspotentialriskfactorforqfever
AT reichandreas livecelltherapyaspotentialriskfactorforqfever
AT cusslerklaus livecelltherapyaspotentialriskfactorforqfever
AT jehlherrmann livecelltherapyaspotentialriskfactorforqfever
AT burckhardtflorian livecelltherapyaspotentialriskfactorforqfever

Ejemplares similares